Gene therapy by small fragment homologous replacement

Chemistry: molecular biology and microbiology – Process of mutation – cell fusion – or genetic modification – Introduction of a polynucleotide molecule into or...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

435325, 435366, 435371, C12N 510, C12N 1563

Patent

active

060109084

ABSTRACT:
A method for gene therapy using small fragment homologous replacement. The method introduces small fragments of exogenous DNA into regions of endogenous genomic DNA virtually homologous to the exogenous DNA. The exogenous DNA fragments contains sequence modification that correct mutations in the endogenous DNA or introduce mutations that alter cellular or an infecting pathogen phenotype.

REFERENCES:
patent: 4950599 (1990-08-01), Bertling
Marita Gareis, Petra Harrer, Wolf M. Bertling, "Homologous Recombination of Exogenous DNA Fragments with Genomic DNA in Somatic Cells of Mice"Cell. Mol. Biol. (1991) 37:191-203.
Wolf M. Bertling, Marita Gareis, Valentina Paspaleeva, Andreas Zimmer, Jeorge Kreuter, Eberhard Nurnberg, and Petra Harrer, Use of Liposomes, Viral Capsids, and Nanoparticles as DNA Carriers; Biotechnol. Applied Biochem. (1991) 13:390-405
Eric Alton & Duncan Geddes, A mixed message for cystic fibrosis gene therapy, Nature Genetics, vol. 8, pp. 8-9, Sep. 1994.
James J. Logan et al, Cationic lipids for reporter gene and CFTR transfer to rat pulmonary epithelium, Gebe Therapy 2, pp. 38-49, 1995.
Eric J. Sorscher et al, Gene Therapy for Cystic Fibrosis Using Cationic Liposome Mediated Gene Transfer: A Phase I Trial of Safety and Efficacy in the Nasal Airway, Human Gene Therapy, 5:1259-1277, Oct. 1994.
James M. Wilson et al, Gene Therapy of Cystic Fibrosis Lung Disease Using E1 Deleted Adenoviruses: A Phase I Trial, Human Gene Therapy 5:501-519, 1994.
Natasha J. Caplen et al, Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis, Nature Medicine, vol. 1, No. 1, Jan. 1995.
Richard M. Boucher et al, Gene Therapy for Cystic Fibrosis Using E1-Deleted Adenovirus: A Phase I Trial in the Nasal Cavity, Human Gene Therapy 5:516-639, 1994.
Mitchell J. Goldman et al, Gene therapy in a xenograft model of cystic fibrosis lung corrects chloride transport more effectively than the sodium defect, Nature Genetics, vol. 9, Feb. 1995.
Joe Palca, The Promise of a Cure, Discover, pp. 79-86, Jun. 1994.
Joseph Zabner et al, Adenovirus-Mediated Gene Transfer Transiently Correct the Chloride Transport Defect in Nasal Epithelia of Patients with Cystic Fibrosis, Cell, vol. 75, pp. 207-216, Oct. 22, 1993.
Terrence R. Flotte et al, An improved system for packaging recombinant adeno-associated virus vectors capable of in vivo transduction, Gene Therapy 2, pp. 29-37, 1995.
Gene therapy for cystic fibrosis, Nature Medicine, vol. 1, No. 3, pp. 182-184, Mar. 3, 1995.
Deborah Erickson, Genes to Order, Scientific American, pp. 112-114, Jun. 1992.
James M. Wilson, Vehicles for gene therapy, Nature, vol. 365, pp. 691-692, Oct. 21, 1993.
Sambrook et al., eds. in "Molecular Cloning: A Laboratory Manual", 2nd ed., 1989. Cold Spring Harbor Laboratory Press,, N.Y. pp. 16.30-16.55, 1989.
Shesely et al., 1991, Proceedings of the National Academy of Science, USA (Abstract Only).
Vega, 1991, Human Genetics, 87:245-253.
Cline, 1985, Pharm. Ther. 29:69-92.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Gene therapy by small fragment homologous replacement does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Gene therapy by small fragment homologous replacement, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Gene therapy by small fragment homologous replacement will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1072060

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.